Gut Bacteria Protein Blocks Inflammation by Neutralizing Harmful Bacterial Toxins

Chronic inflammation accelerates aging and contributes to numerous age-related diseases, making the discovery of natural anti-inflammatory mechanisms crucial for longevity research. Scientists have now identified a specific protein from beneficial gut bacteria that could help explain how our microbiome protects against harmful inflammation.

Researchers studied Parabacteroides distasonis, a beneficial gut bacterium known to reduce inflammation. Using advanced protein separation techniques, cell-based assays, and proteomics, they isolated and characterized a protein called A6LA28 from the bacterial membrane. This protein contains a specialized domain that appears designed to bind lipopolysaccharide (LPS), a potent inflammatory toxin produced by harmful bacteria.

Laboratory experiments demonstrated that A6LA28 effectively neutralizes LPS by binding to it directly. When researchers exposed human intestinal cells and immune cells to LPS along with A6LA28, the protein dose-dependently reduced production of inflammatory molecules including IL-8, IL-6, and TNF-α. Structural analysis revealed that the protein's C-terminal region forms a pocket specifically designed for LPS binding, while the N-terminal region appears less critical for function.

These findings have significant implications for healthy aging, as chronic low-grade inflammation (inflammaging) is a hallmark of aging that contributes to cardiovascular disease, neurodegeneration, and metabolic dysfunction. The discovery suggests that maintaining robust populations of P. distasonis through diet, probiotics, or prebiotics could support longevity by naturally reducing inflammatory burden. Additionally, A6LA28 could potentially be developed as a therapeutic protein for treating inflammatory conditions, though further research is needed to confirm its effectiveness in living organisms.